Top of this page
Skip navigation, go straight to the content

ucb-usa.com Newsroom UCB U.S. News

Categories

  • UCB PharmD Fellows Have a Big Impact on Patients

    Posted by Katelyn Snider, U.S. Communications & Public Affairs
    Regulatory_Fellows_for_Blog_1280_960
    UCB Global Regulatory Affairs Fellows (L to R): Howraa Alasker, PharmD and Tanya Chaudhri, PharmD, RPh

    The 2020-2022 UCB Global Regulatory Affairs (GRA) PharmD Fellowship Program, a collaboration with the Industry Pharmacists Organization (IPhO), is a 2-year rotational program located at UCB’s Atlanta campus aimed at growing top regulatory talent for the future. Established in 2017, the Fellowship Program is designed to provide PharmD graduates with the opportunity to learn and experience all aspects of regulatory affairs under the mentorship of experienced preceptors. Applications are being accepted now until November 1, 2019. Learn more about the fellowship from current fellow, Tanya Chaudhri, PharmD, RPh.

    Read more

  • UCB and University of Washington Collaborate on Engaging Community Pharmacists to Improve Care for People Living with Epilepsy

    Posted by Allyson Funk, Head of U.S. Communications and Public Affairs
    UCB_LOGO_1280x960
    UCB is collaborating with the University of Washington to improve care delivery for people living with epilepsy by engaging community pharmacists.

    Read more

  • Announcing the 2019 UCB Family Epilepsy Scholarship Winners and the Addition of 6 New Scholarships

    Posted by Allyson Funk, Head of U.S. Communications and Public Affairs
    ucb_ep_scholarship_1280x960
    UCB is pleased to announce 38 recipients were awarded the 2019 UCB Family Epilepsy Scholarship. This year’s UCB Family Epilepsy Scholarship program includes six additional awards. We awarded a $10,000 Joe D’Souza Memorial Scholarship along with five additional $5,000 scholarships for 2019.

    Read more

  • UCB and DEARhealth Collaborate on New Software to Improve Patient Care

    Andrea_Epilepsy_Blog_1280x960
    UCB is collaborating with DEARhealth, Inc. to improve care delivery for people living with epilepsy. More than 1 in 26 Americans will experience epilepsy at some point in their lives, and many also suffer from stigma around their condition.

    Read more

  • Beyond What’s Required: Thoughtful Clinical Results

    DIA_for_blog
    UCB is in San Diego for DIA-Global 2019 this week. Ahead of her presentation, Liz Roberts, our Global Public Policy Lead, shares insights from the industry perspective on clinical trial disclosure and data transparency, and what UCB is doing to keep patients at the center of our work in this space. For more, see Liz speak today, June 25, 2019 at 2:00 p.m. in room 4 (session #260).

    Read more

  • UCB’s Global Clinical Development in Raleigh

    Posted by Becky Malone, Engagement and Communications
    RTP_Blog
    From discovery to development to delivery, how we do business has been transformed and redesigned around the patient’s individual experience. At UCB, patients are at the heart of everything we do, inspiring us and driving the ways in which we research, develop, and study differentiated treatments for patients. For 18 years, UCB BioSciences has been in the Research Triangle Park (RTP) in North Carolina and is an integral part of UCB’s mission to bring differentiated medicines to patients.

    Read more

  • UCB Boston Research is Advancing Medical Innovation

    Posted by Katelyn Snider, U.S. Communications and Public Affairs
    UCB_Boston Promo_blog_1280x960_v2_1
    Every day, UCB researchers come to work driven by a singular purpose – to create value for people living with severe disease. That’s because, across the world, patients depend on the important work of scientific research to find new medical innovations that will help them achieve their goals. From the “breakthrough” moments in discovery, development, and delivery, we are dedicated to finding solutions for the unmet needs of patients.

    Read more

  • Supporting STEM in North Carolina

    Posted by Becky Malone, Engagement and Communications
    blog2lg


    Wake County, NC teachers visiting for UCB’s annual SummerSTEM day. (L to R) Andrew Oliver, Bruce Mamel, Michelle Woods, Sarah Brown, Ken Whisler, Cherilyn Murray, Antwanna Pegues Simmons, and Laura Williford.

    At UCB, we are committed to accelerating scientific discoveries by supporting innovation — leading to the discovery of new solutions that help patients achieve their goals. As part this commitment, we believe it is important to support STEM education in our local communities to help inspire the next generation of scientists.

    Read more

  • AGA IBD Parenthood Project provides guidance about pregnancy for women with IBD and their health care team

    Guest Post by Aimee Frank, Senior Director, Communications, American Gastroenterological Association
    AGA_blog_1280_960_
    A key underserved patient population is women of childbearing age managing chronic conditions. In honor of Mother’s Day, Aimee Frank, Senior Director of Communications at the American Gastroenterological Association (AGA), shares about the IBD Parenthood Project, an effort led by the AGA with support by UCB, to help address the misperceptions women with inflammatory bowel disease and their healthcare providers experience throughout family planning.

    Read more

  • UCB Flies in to DC to Advocate for Innovation

    Posted by Katelyn Snider, U.S. Communications and Public Affairs
    phrma_fly_in_for_blog
    Earlier this week, researchers from across UCB met in Washington, D.C. for the PhRMA Researcher Fly-In. While on Capitol Hill, the UCB team visited the offices of Representatives Doug Collins, Lucy McBath, and David Price, and Senators Johnny Isakson, Richard Burr, and Thom Tillis and walked their staff through the 15-year journey (on average) of how a new medicine is discovered, developed, and delivered at UCB. Each researcher, representing a different part of the drug development process, shared their personal stories about why they’re motivated each day to continue to innovate for patients.

    Read more